|
Market Cap (5-Jun) $23,079,360 (1,609th) |
Close (25-Oct) $0.048 |
Volume (25-Oct) 0 |
Shortsold (25-Jun) 3,768 (0.00%) (647th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.019 |
SUD released this announcement to the ASX on 16 February 2021, 8:19. The announcement is marked as price sensitive, and is 2 page(s) in length and 181.43kb in size.
You can view all announcements from SUD and see how they appear on a price chart on the announcements page.
At the date of this announcement, SUD was 0.001% short sold according to ASIC data. It was ranked the 647th most shorted stock on the ASX. It remains ranked 647th as of the latest reported data (25 June 2021).
| Other Recent Announcements from SUD | |
|---|---|
| SUDA becomes Arovella Therapeutics | 22 October 2021, 8:20 |
| Chile Ministry of Health Approval Granted for ZolpiMist | 21 October 2021, 10:00 |
| Results of General Meeting | 14 October 2021, 13:51 |
| Zelira Therapeutics Feasibility Study Update | 16 February 2021, 8:19 |
| Results of General Meeting | 29 January 2021, 15:32 |
| GM presentation | 29 January 2021, 9:12 |
| Quarterly Appendix 4C and Activities Report | 25 January 2021, 8:40 |
You must be logged in to post a reply.
